BR9707943B - Composto, e, glutarimida - Google Patents

Composto, e, glutarimida

Info

Publication number
BR9707943B
BR9707943B BRPI9707943-0A BR9707943A BR9707943B BR 9707943 B BR9707943 B BR 9707943B BR 9707943 A BR9707943 A BR 9707943A BR 9707943 B BR9707943 B BR 9707943B
Authority
BR
Brazil
Prior art keywords
glutarimide
compound
Prior art date
Application number
BRPI9707943-0A
Other languages
English (en)
Other versions
BR9707943A (pt
BR9707943C8 (pt
Inventor
Philippe Camus
Marcel Descamps
Joel Radisson
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9707943(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR9707943A publication Critical patent/BR9707943A/pt
Publication of BR9707943B publication Critical patent/BR9707943B/pt
Publication of BR9707943C8 publication Critical patent/BR9707943C8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI9707943-0C8A 1996-03-07 1997-03-05 Composto, e, glutarimida. BR9707943C8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602880A FR2745811B1 (fr) 1996-03-07 1996-03-07 Glutarimide disubstitue procede pour sa preparation, et son utilisation
PCT/FR1997/000388 WO1997032852A1 (fr) 1996-03-07 1997-03-05 Glutarimides 3-aryl-3-carboxyalkyl substitues, leur preparation par cyclisation d'acides dicarboxyliques de la 4-aryl-4-cyanoheptane et leur utilisation pour la preparation de 3-aryl-3-hydroxyalkylpiperidines

Publications (3)

Publication Number Publication Date
BR9707943A BR9707943A (pt) 1999-07-27
BR9707943B true BR9707943B (pt) 2008-05-20
BR9707943C8 BR9707943C8 (pt) 2014-11-18

Family

ID=9489959

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9707943-0C8A BR9707943C8 (pt) 1996-03-07 1997-03-05 Composto, e, glutarimida.

Country Status (19)

Country Link
US (2) US6008360A (pt)
EP (1) EP0888304B1 (pt)
JP (1) JP3116051B2 (pt)
AR (1) AR006139A1 (pt)
AT (1) ATE206399T1 (pt)
AU (1) AU2163497A (pt)
BR (1) BR9707943C8 (pt)
CA (1) CA2244771C (pt)
CY (1) CY2276B1 (pt)
DE (1) DE69707114T2 (pt)
DK (1) DK0888304T3 (pt)
ES (1) ES2165594T3 (pt)
FR (1) FR2745811B1 (pt)
MY (1) MY128754A (pt)
NO (1) NO314498B1 (pt)
PT (1) PT888304E (pt)
TW (1) TW381080B (pt)
WO (1) WO1997032852A1 (pt)
ZA (1) ZA971999B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787449B3 (fr) * 1998-12-15 2001-01-12 Sanofi Sa Derives de 3-phenyl-2,6-dioxopiperidin-3-yl propionamide et leur procede de preparation
FR2787448B3 (fr) 1998-12-18 2001-01-12 Sanofi Sa Ester d'alkyle inferieur de l'acide 3-(3,4-dihalogenophenyl) -2,6-dioxopiperidine3-propionique et son mode de preparation
DE10002509A1 (de) 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
WO2002046156A2 (en) 2000-12-06 2002-06-13 Sepracor, Inc. 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3379731A (en) * 1967-06-15 1968-04-23 Ciba Geigy Corp 1, 4-dihydro-1, 4-ethano-isoquinolines
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
BE787767A (fr) * 1971-08-21 1973-02-19 Merck Patent Gmbh Procede de preparation d'amides d'acides oxocarboxyliques et d'acides oxocarboxyliques
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5625060A (en) * 1991-05-03 1997-04-29 Elf Sanofi Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present
US5583134A (en) * 1992-09-30 1996-12-10 Sanofi 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.

Also Published As

Publication number Publication date
CY2276B1 (en) 2003-07-04
ES2165594T3 (es) 2002-03-16
NO984083D0 (no) 1998-09-04
US6242607B1 (en) 2001-06-05
JPH11506124A (ja) 1999-06-02
BR9707943A (pt) 1999-07-27
MY128754A (en) 2007-02-28
AU2163497A (en) 1997-09-22
WO1997032852A1 (fr) 1997-09-12
DE69707114D1 (de) 2001-11-08
EP0888304B1 (fr) 2001-10-04
PT888304E (pt) 2002-02-28
TW381080B (en) 2000-02-01
US6008360A (en) 1999-12-28
NO314498B1 (no) 2003-03-31
NO984083L (no) 1998-09-04
ZA971999B (en) 1997-09-09
EP0888304A1 (fr) 1999-01-07
FR2745811A1 (fr) 1997-09-12
BR9707943C8 (pt) 2014-11-18
AR006139A1 (es) 1999-08-11
DK0888304T3 (da) 2002-03-04
JP3116051B2 (ja) 2000-12-11
CA2244771A1 (en) 1997-09-12
FR2745811B1 (fr) 1998-05-22
CA2244771C (en) 2004-07-13
DE69707114T2 (de) 2002-06-06
ATE206399T1 (de) 2001-10-15

Similar Documents

Publication Publication Date Title
ID19430A (id) Senyawa senyawa heterosiklik
BR9709230A (pt) Composto
NO975894L (no) Foringsr°rpakning
ATE208395T1 (de) Thiophenopyrimidine
BR9707051A (pt) Composto
DE69711699D1 (de) Lochsäge
ATE262512T1 (de) Arylalkanoylpyridazine
ID18010A (id) Oligosakarida termodifikasi
KR980000769U (ko) 병상
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
BR9711205A (pt) Composto
NO992852D0 (no) Basisstr°mningsenhet
DK0923562T3 (da) Substituerede p-trifluormethylphenyluraciler
DE59707428D1 (de) Substituierte 1-methyl-3-benzyluracile
ATE275146T1 (de) Substituierte pyrazol-3-ylbenzazole
BR9707943B (pt) Composto, e, glutarimida
DE59712222D1 (de) Substituierte phenyluracile
DE59708674D1 (de) Substituierte 3-phenylpyrazole
KR970058619U (ko) 공동용 납골함
FI2507U1 (fi) Hirsielementti
BR9603362A (pt) Composto bromatológico
KR970051099U (ko) 개량샷시
ITMT960002U1 (it) D e d
NO984987D0 (no) Sammenf°yningsorgan
ATE267568T1 (de) Epithese

Legal Events

Date Code Title Description
TE Change of address
PC Transfer

Free format text: MOMSEN, LEONARDOS & CIA TRANSFERIDO DE SANOFI

HHT Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Free format text: TRANSFERIDO DE: SANOFI REF. RPI 1573 DE 28/02/2001. COD. 25.1. ITEM (71)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/05/2008, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 1950 DE 20/05/2008, CODIGO DO DESPACHO (16.1). PRIORIDADE UNIONISTA, ITEM (30)

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 14A E 15A ANUIDADE(S), CONFORME ART. 87 DA LPI 9.279.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AO DESPACHO 24.3 PUBLICADO NA RPI 2184 DE 13/11/2012.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061557/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132378-91.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: RECKITT BENCKISER HEALTHCARE (UK) LIMITED, SANOFI-AVERTIS, SEPSICURE, L.L.C, THE AUSTRALIAN NATIONAL UNIVERSITY, THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY UNDIVIDED TRINITY OF QUEEN ELIZA

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: MANUTENCAO DA EXTINCAO - ART. 78 INCISO IV DA LPI

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 1950 DE 20/05/2008 RETIFICADA NA RPI 2039 DE 02/02/2010, QUANTO AO PRAZO DE VALIDADE CONFORMEDECISAO DA 13A VARA FEDERAL DO RIO DE JANEIRO.

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.061557/13 SECAO JUDICIARIA DO RIO DE JANEIRO - 13A VARA FEDERAL PROCESSO NO 2013.51.01.132378-8 AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU(S): RECKITT BENCKISER HEALTHCARE (UK) LIMITED, SANOFI-AVENTIS, SEPSICURE, L.L.C. E THE AUSTRALIAN NATIONAL UNIVERSITY DECISAO: ANTECIPO OS EFEITOS DA TUTELA, A FIM DE DETERMINAR A IMEDIATA READEQUACAO DO PRAZO DE VIGENCIA DAS PATENTES PI9607679-8, PI9707943-0, PI9508584-0 E PI9608041-8 PARA VINTE ANOS CONTADOS A PARTIR DOS RESPECTIVOS DEPOSITOS, NOS TERMOS DO PARAGRAFO UNICO DO ART. 229 C/C O CAPUT DO ART. 40 DA LPI, CONFORME TABELA A SEGUIR: TITULAR: RECKITT BENCKISER HEALTHCARE (UK) LIMITED - PI9607679-8 - PRAZO DE VIGEN